Patent Office Grants Interim Extension to CORLOPAM Patent

Summary

The U.S. Patent and Trademark Office has issued a certificate under the Patent Term Extension Act for a one-year extension of the patent term for CORLOPAM, a drug product containing fenoldopam mesylate, to allow for the continued development and commercialization of the product.